Founder of Helixometry
tel: (408) 891-7187
Aug 1, 2002
FractoGene Patent Pending. Initial offerings outlined, first in a closely held manner.
FractoGene of HelixoMetry is marketed in 7 overlapping Business Models
"Seven Sisters":
(1) Translation Memory Company, Partnership / M/A
Advantage: Most immediate, as repetitive "language sequences" are already mined by software of medium-sized Companies. Provides a jump-start of Software (SDL, Trados etc. software development is catapulted - instantly connecting to Big Pharma and other major clientele, also providing an IPO value quantum jump for Translation Memory breaking into BioTech). Overlaps with 2,3,7
SDL (Pre-Patent Agreement Signed, May 2002)
TRADOS (Talks since March 2002)
IBM Translation Manager (Talks since May 2002)
ATRIL DÉJÁ VU
SYSTRAN
LISA
XPLANATION LANTWORKS
TRANSCEND
(2) "Big Pharma" Pharmaceutical Company, M/A, Director of "in house" Data-Base and Drug Discovery IT. Overlaps with
(3) "Big IT" Information Technology Company, Acquisition
(4) Bioinformatics Company Cooperation / Partnership
(5) Genomics Data-Base Company, M/A / Partnership
(6) University R&D Center, M/A / Professorship / Directorship
(7) Regional Center Uniqueness Cooperation / Directorship